ArticleslgStudy

biology

Paraneoplastic cerebellar degeneration

Paraneoplastic cerebellar degeneration is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Paraneoplastic cerebellar degeneration rather than just read about it. In short: Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic syndrome associated with a broad variety of tumors including lung cancer, ovarian cancer, breast cancer, Hodgkin’s lymphoma and others. PCD is a rare condition that occurs in less than 1% of cancer patients.

Key takeaways

  • Paraneoplastic cerebellar degeneration belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Paraneoplastic cerebellar degeneration to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Paraneoplastic cerebellar degeneration from memory before moving on to harder problems.

Reference excerpt

Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic syndrome associated with a broad variety of tumors including lung cancer, ovarian cancer, breast cancer, Hodgkin’s lymphoma and others. PCD is a rare condition that occurs in less than 1% of cancer patients. As is the case with other paraneoplastic syndromes, PCD is believed to be due to an autoimmune reaction targeted against components of the central nervous system, mostly to Purkinje cells. It is thought to be triggered when tumor cells (in PCD, most commonly ovarian or breast cancer) ectopically express proteins normally expressed in the cerebellum. This is believed to trigger an anti-tumor immune response that may be clinically significant, but also an anti-neural immune response. A broad spectrum of neuronal and glial proteins has been identified as target antigens in PCD.

Presentation Neurological symptoms may include, among others, dysarthria, truncal, limb and gait ataxia and nystagmus. Symptoms often develop subacutely and progress rapidly over a period of weeks or months to a plateau period that can last for months to years and which often reflects complete loss of Purkinje cells.

Pathophysiology The anti-Purkinje cell antibodies originally described in PCD led to the hypothesis that the antibody might be pathogenic, much as earlier studies had demonstrated pathogenicity of anti-acetylcholine receptor antibodies in myasthenia gravis. However, when the antibody was used to clone the cDNA encoding the cdr2 antigen, it was found to be an intracellular protein. This led to the suggestion that there might be a cell-mediated component (T cell) in disease pathogenesis. cdr2 antigen-specific CD8+ T cells were subsequently described in more anti-Yo-positive PCD patients. These T cells are likely components in both the anti-tumor immune response and in the neuronal degeneration.

Diagnosis Of particular note, PCD symptoms precede the diagnosis of the underlying cancer in the majority of cases, and often present insidiously and progress rapidly for weeks to months to a severely disabled state followed by a variable plateau period that can last for months to years. Therefore, newly developing cerebellar ataxia should always prompt proper diagnostic measures to exclude PCD.

Treatment Tumor removal is still the therapeutic mainstay with very early treatment being essential to prevent irreversible neuronal loss. Immunosuppressive or immunomodulatory treatments are often ineffective. There may be a role for high-dose gammaglobulin therapy in the treatment of PCD, but due to the rare occurrence of this disease, controlled trials of this therapy may be difficult.

References

External links

Worked examples

Example 1 — a first encounter with Paraneoplastic cerebellar degeneration

Start with the simplest possible case. Write down what Paraneoplastic cerebellar degeneration claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Paraneoplastic cerebellar degeneration before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Paraneoplastic cerebellar degeneration ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Paraneoplastic cerebellar degeneration

In research
Paraneoplastic cerebellar degeneration appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Paraneoplastic cerebellar degeneration in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Paraneoplastic cerebellar degeneration is common in secondary-school and first-year university syllabi. It links to neighbouring topics Paraneoplastic syndromes, so understanding it makes those chapters shorter.
In everyday life
Look for Paraneoplastic cerebellar degeneration outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Paraneoplastic cerebellar degeneration” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Paraneoplastic cerebellar degeneration in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Paraneoplastic cerebellar degeneration means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Paraneoplastic cerebellar degeneration out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Paraneoplastic cerebellar degeneration in simple terms?

Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic syndrome associated with a broad variety of tumors including lung cancer, ovarian cancer, breast cancer, Hodgkin’s lymphoma and others. PCD is a rare condition that occurs in less than 1% of cancer patients.

Why does Paraneoplastic cerebellar degeneration matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Paraneoplastic cerebellar degeneration?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Paraneoplastic cerebellar degeneration.

Tags

  • Paraneoplastic syndromes

Keep exploring